文献速递脑血管病

缺血性卒中患者mRS至EQ-5D-5L的映射研究

Mapping the mRS Into the EQ-5D-5L in Patients With Ischemic Stroke.
PubMed 文献 · Stroke · 2026-04-29

本研究汇总3项荷兰多中心III期临床试验数据,将缺血性卒中后3个月的改良Rankin量表(mRS)评分映射为EQ-5D-5L效用值。采用多种直接和间接映射算法,以自助法评估模型性能,并在外部验证集中验证。结果显示多项式logit模型为优选算法,并给出了各mRS评分对应的平均效用值,可用于成本-效果分析中质量调整生命年的直接估算。

要点

  • mRS与EQ-5D-5L自理、日常活动和行动维度相关性最强。
  • 多项式logit模型是优选的间接映射算法。
  • 各mRS评分对应的平均效用值可直接用于估算QALYs。

核心结论

  • 提供的平均效用权重可用于从mRS评分直接估算质量调整生命年。
  • 多项式logit模型可用于从具有不同国家效用 tariff 的新数据集中推导效用值。

研究设计与样本

  • 汇总3项荷兰多中心III期临床试验(MR CLEAN-NO-IV、MR CLEAN-MED和MR CLEAN-LATE)的数据。
  • 在卒中后3个月通过电话访谈评估mRS和EQ-5D-5L。
  • 探索多种直接和间接映射算法,并使用自助法在全测试集及独立(mRS 0-2)和依赖(mRS 3-5)患者中评估模型性能。
  • 结果在来自荷兰横断面研究的外部验证集中进行验证。

主要发现

  • EQ-5D-5L自理、日常活动和行动维度与mRS相关性最强(ρ=0.46-0.70)。
  • 疼痛和焦虑维度的相关系数相对较差(ρ=0.37-0.45)。
  • 汇总数据集中,中位(四分位距)年龄为71(62-79)岁,56%为男性。
  • 各mRS评分的平均(标准差)拟合效用值:mRS 0:0.947(0.004);mRS 1:0.860(0.009);mRS 2:0.758(0.013);mRS 3:0.597(0.017);mRS 4:0.352(0.017);mRS 5:0.147(0.017)。

关键数值与推荐

  • 多项式logit模型被确定为优选的映射算法。
  • 各mRS评分对应的平均效用值如上所述。

临床怎么用

  • 在成本-效果分析中,可使用提供的平均效用权重从mRS评分直接估算QALYs。
  • 对于具有不同国家效用 tariff 的新数据集,可使用多项式logit模型推导效用值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mapping concerns the cross-walking of one health-related quality of life instrument to another. This study aimed to translate the modified Rankin Scale (mRS) score at 3 months after ischemic stroke into 5-level version of the EQ-5D (EQ-5D-5L)-based utility values, which may be used for the derivation of quality-adjusted life years for cost-effectiveness analyses. METHODS: Data from 3 Dutch multicenter phase III clinical trials in ischemic stroke were pooled (MR CLEAN [Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands]-NO-IV, MR CLEAN-MED, and MR CLEAN-LATE). The mRS and EQ-5D-5L were assessed by telephone interview at 3 months poststroke. The correlation (Spearman coefficient) between the mRS and each EQ-5D-5L domain was assessed. Various direct and indirect mapping algorithms were explored. Model performance (predictive ability) was assessed using bootstrapping in the full testing set (mRS score 0-5) and in patients with independent (0-2) and dependent (3-5) mRS scores separately. Results were validated in an external validation set derived from a cross-sectional Dutch study. Final utility estimates per mRS score were assessed in the pooled trial and external validation data set. RESULTS: The EQ-5D-5L dimensions self-care, daily activities, and mobility demonstrated the strongest correlation to the mRS (ρ=0.46-0.70). Correlation coefficients of the pain and anxiety dimensions were relatively poor (ρ=0.37-0.45). Indirect mapping with a multinomial logit model was identified as the preferred mapping algorithm. In the pooled data set, the median (interquartile range) age was 71 (62-79), and 56% of patients were male. Mean (SD) fitted utility values per mRS score were; mRS score 0: 0.947 (0.004); mRS score 1: 0.860 (0.009); mRS score 2: 0.758 (0.013); mRS score 3: 0.597 (0.017); mRS score 4: 0.352 (0.017); and mRS score 5: 0.147 (0.017). CONCLUSIONS: The mean utility weights provided in this study may be used for the direct estimation of quality-adjusted life years from mRS scores. Furthermore, the multinomial logit model may be used to derive utility values from new data sets with different country-specific utility tariffs. Our results are ideally suited for application in cost-effectiveness analyses.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Pinckaers FME, Grutters JPC, Evers SMAA, et al. Mapping the mRS Into the EQ-5D-5L in Patients With Ischemic Stroke. Stroke. 2026. PMID: 42052683. doi:10.1161/STROKEAHA.126.055741

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。